Founded by interventional neuroradiologist Bryan Pukenas, MD, and medical-device executive Kamna Giare-Patel, Cerespectus is a Philadelphia medical-device company focused on making central nervous system gene-therapy delivery safer and more accessible. Its developing Esperanza catheter is designed for targeted treatment delivery through lumbar access, with the aim of helping more physicians perform the procedure. The device is not FDA cleared or commercially available.